Skip to main content

Research Repository

Advanced Search

Outcomes and Contemporary Trends in Surgical vs Transcatheter Aortic Valve Replacement in Patients with Chronic Obstructive Pulmonary Disease

Khan, Muhammad Zia; Alharbi, Anas A.; Zahid, Salman; Khan, Muhammad U.; Ullah, Waqas; Sattar, Yasar; Rashid, Muhammad; Kichloo, Asim; Munir, Muhammad Bilal; Balla, Sudarshan

Authors

Muhammad Zia Khan

Anas A. Alharbi

Salman Zahid

Muhammad U. Khan

Waqas Ullah

Yasar Sattar

Asim Kichloo

Muhammad Bilal Munir

Sudarshan Balla



Abstract

Background
Chronic obstructive lung disease (COPD) is a common morbidity among patients referred for aortic valve replacement. The objective of the present study is to assess trends and outcomes of COPD patients undergoing either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) for severe aortic stenosis.

Methods
We analyzed the National Inpatient Sample database from January 2012 to December 2017 using the International Classification of Diseases, 9th and 10th Revision Clinical Modifications to identify all patients with COPD aged ≥50 years who underwent either TAVR or SAVR for aortic stenosis. To account for potential bias, 1:1 propensity-matched analysis was performed. Logistic regression was used for predictors of mortality in the cohort. Linear regression was used for trend analysis.

Results
Of the total of 95,555 cases, 40,080 underwent TAVR whereas 49,985 underwent SAVR. In-hospital mortality for the propensity-matched cohorts was higher in the SAVR cohort compared to the TAVR group (4.6% vs. 2.5%; p < 0.001). Respiratory complications were also higher in the SAVR group (7.5% vs. 3.7%; p < 0.001) but were less likely to have a permanent pacemaker placement (5.3% vs. 10.8%, p < 0.001). Length of stay (11.8 days [standard deviation (SD), 8.8] vs. 6.4 days [SD, 6.8]) and cost of stay ($244,657 [SD, $183,333] vs. $229,524 [SD, $146,994]) were favorable toward TAVR as compared to SAVR. In-hospital mortality has declined over the study period in the TAVR group from 4.8% to 1.5%.

Conclusion
TAVR has more favorable in-hospital outcomes in patients with COPD compared to SAVR.

Citation

Khan, M. Z., Alharbi, A. A., Zahid, S., Khan, M. U., Ullah, W., Sattar, Y., Rashid, M., Kichloo, A., Munir, M. B., & Balla, S. (2021). Outcomes and Contemporary Trends in Surgical vs Transcatheter Aortic Valve Replacement in Patients with Chronic Obstructive Pulmonary Disease. Structural Heart, 5(4), 401-409. https://doi.org/10.1080/24748706.2021.1931736

Journal Article Type Article
Acceptance Date May 12, 2021
Online Publication Date Jul 12, 2021
Publication Date 2021-07
Deposit Date Jun 19, 2023
Journal Structural Heart
Print ISSN 2474-8706
Electronic ISSN 2474-8714
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 5
Issue 4
Pages 401-409
DOI https://doi.org/10.1080/24748706.2021.1931736
Keywords Cardiology and Cardiovascular Medicine
Public URL https://keele-repository.worktribe.com/output/488847
Additional Information Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.; Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ushj20; Received: 2021-01-29; Revised: 2021-05-06; Accepted: 2021-05-12; Published: 2021-07-12